Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
To the Editor:
I found the results of the CheckMate 067 study reported by Larkin and colleagues (July 2 issue)
1
to be extremely encouraging. Like many readers, I believe that these findings will rapidly evolve into a new standard of care and a change in daily practice. However, the high proportion of patients in the nivolumab-plus-ipilimu...
Alternative Titles
Full title
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1716935378
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1716935378
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc1509660
